Deleterious ATM mutations in the residual allele can be found in 36% of the CLL patients with a del(11q) and are associated with a poorer prognosis, compared with patients with del(11q) alone (84–86). The gene discussed is ATM; the disease is B-cell chronic lymphocytic leukemia.